Location and Topography
The palmar interossei belong to the central compartment of the hand muscles (compartimentum palmaris medius). There are three such muscles in total, situated within the 2nd, 3rd, and 4th intermetacarpal spaces.
The central fascial space of the palm is bordered by four walls:
- Anterior wall: Palmar aponeurosis (aponeurosis palmaris).
- Lateral wall: Vertical part of the lateral intermuscular septum.
- Medial wall: Medial intermuscular septum.
- Posterior wall: Deep fascia covering the palmar interossei and the horizontal part of the lateral intermuscular septum.
Structure: Origin and Insertion
The palmar interossei are unipennate muscles. Their anatomical landmarks are:
- Origin: Shafts of the second, fourth, and fifth metacarpal bones.
- Insertion: Dorsal digital expansions (extensor hoods) and the bases of the proximal phalanges of digits II, IV, and V; the fibers are directed toward the axial (third) digit.
Biomechanics and Functions
- Adduction: Adducts digits V, IV, and II toward the midline axis represented by digit III.
- Flexion and Extension: Flexes the proximal phalanx and extends the middle and distal phalanges.
Innervation
All interossei muscles of the hand—both palmar and dorsal—are innervated by the deep branch of the ulnar nerve (ramus profundus n. ulnaris).
The deep branch of the ulnar nerve enters the sub-tendinous space of the central compartment from the medial side.
It also innervates the 3rd and 4th lumbricals, the adductor pollicis, and the deep head of the flexor pollicis brevis.
Note: Other Meanings of PAD
In medical literature, the acronym PAD serves as a mnemonic for the palmar interossei, but has other contexts:
- Padua Prediction Score: Used to assess the risk of venous thromboembolism in hospitalized medical patients, including acute exacerbations of Crohn's disease, and to evaluate risk during menopausal hormone therapy continuation. The PADUA system is also used to evaluate the renal rim in renal cell carcinoma.
- PAD Regimen: Bortezomib + doxorubicin + dexamethasone; recommended for plasma cell leukemia and listed among treatment regimens for multiple myeloma.